Amarin Corporation plc (AMRN) Financial Statements (2024 and earlier)

Company Profile

Business Address SPACES SOUTH DOCKLANDS, BLOCK C
DUBLIN 2, D02 VK60
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments320,662312,914304,371309,361303,701313,233
Cash and cash equivalents270,814232,995191,412217,666240,498228,001
Short-term investments49,84879,919112,95991,69563,20385,232
Restricted cash and investments5245245235233,9203,918
Receivables122,400122,730133,236130,990123,379143,942
Inventory, net of allowances, customer advances and progress billings254,461227,021225,813228,732227,606225,772
Inventory254,461227,021225,813228,732227,606225,772
Other undisclosed current assets19,46443,30619,87819,49227,91432,259
Total current assets:717,511706,495683,821689,098686,520719,124
Noncurrent Assets
Inventory, Noncurrent91,792122,318143,730163,620187,964210,252
Operating lease, right-of-use asset8,5108,9789,1909,0748,4628,599
Property, plant and equipment1471791878749991,137
Long-term investments and receivables  675441,2752,26411,395
Long-term investments  675441,2752,26411,395
Intangible assets, net (including goodwill)19,67620,37721,07821,78021,63822,274
Intangible assets, net (excluding goodwill)19,67620,37721,07821,78021,63822,274
Other noncurrent assets1,3951,6041,638458456456
Total noncurrent assets:121,520153,523176,367197,081221,783254,113
TOTAL ASSETS:839,031860,018860,188886,179908,303973,237
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities53,36254,30958,77986,57693,157116,312
Accounts payable53,36254,30958,77964,60293,157116,312
Accrued liabilities   21,974  
Deferred revenue2,0252,0252,1992,1992,1982,198
Other liabilities   35,643  
Other undisclosed current liabilities211,304214,598183,264135,061192,001243,064
Total current liabilities:266,691270,932244,242259,479287,356361,574
Noncurrent Liabilities
Long-term debt and lease obligation:     9,92410,174
Liabilities, other than long-term debt19,19219,95831,15331,36723,19621,446
Deferred revenue2,9493,33112,70213,14713,49913,810
Other liabilities7,2737,1558,6108,2059,6977,636
Operating lease, liability8,9709,4729,84110,0159,92410,174
Total noncurrent liabilities:19,19219,95831,15331,36733,12031,620
Total liabilities:285,883290,890275,395290,846320,476393,194
Equity
Equity, attributable to parent553,148569,128584,793595,333587,827580,043
Common stock302,318301,906301,285299,002298,596294,659
Treasury stock, value(63,743)(63,464)(63,277)(61,770)(61,585)(61,419)
Additional paid in capital1,895,1551,891,9571,890,4961,885,3521,878,9231,869,770
Accumulated deficit(1,580,582)(1,561,271)(1,543,711)(1,527,251)(1,528,107)(1,522,967)
Total equity:553,148569,128584,793595,333587,827580,043
TOTAL LIABILITIES AND EQUITY:839,031860,018860,188886,179908,303973,237

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues66,05680,16785,97590,24589,87894,440
Cost of revenue
(Cost of Goods and Services Sold)
(23,560)(23,199)(25,794)(26,641)(23,941)(35,810)
Other undisclosed gross profit (12,674)(14,300)(12,254) (3,078)(15,000)
Gross profit:29,82242,66847,92763,60462,85943,630
Operating expenses(51,273)(66,627)(65,268)(73,190)(68,003)(106,462)
Operating loss:(21,451)(23,959)(17,341)(9,586)(5,144)(62,832)
Nonoperating income (expense)(575)3,0436244,069511(2,255)
Other nonoperating income (expense) (575)3,043624 511(2,255)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (15)  
Income (loss) from continuing operations before equity method investments, income taxes:(22,026)(20,916)(16,717)(5,532)(4,633)(65,087)
Other undisclosed income (loss) from continuing operations before income taxes3,2163,0012,221(1,241)750288
Loss from continuing operations before income taxes:(18,810)(17,915)(14,496)(6,773)(3,883)(64,799)
Income tax expense (benefit)(501)355(1,964)7,629(1,257)(5,157)
Income (loss) from continuing operations:(19,311)(17,560)(16,460)856(5,140)(69,956)
Loss before gain (loss) on sale of properties:(5,140)(69,956)
Net income (loss) available to common stockholders, diluted:(19,311)(17,560)(16,460)856(5,140)(69,956)

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net income (loss):(19,311)(17,560)(16,460)856(5,140)(69,956)
Comprehensive income (loss), net of tax, attributable to parent:(19,311)(17,560)(16,460)856(5,140)(69,956)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: